These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34952193)

  • 1. Virtual screening and in vitro assays of novel hits as promising DPP-4 inhibitors.
    Pantaleão SQ; Philot EA; de Paula H; Inês de Sairre M; Lima AN; Pires LM; Alves Dos Santos R; Scott AL; Honorio KM
    Biochimie; 2022 Mar; 194():43-50. PubMed ID: 34952193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays.
    Guasch L; Ojeda MJ; González-Abuín N; Sala E; Cereto-Massagué A; Mulero M; Valls C; Pinent M; Ardévol A; Garcia-Vallvé S; Pujadas G
    PLoS One; 2012; 7(9):e44971. PubMed ID: 22984596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the molecular dynamics of type-2 diabetes drug target DPP-4 and its interaction with Sitagliptin and inhibitor Diprotin-A.
    Chakraborty C; Hsu MJ; Agoramoorthy G
    Cell Biochem Biophys; 2014 Nov; 70(2):907-22. PubMed ID: 24809328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among
    Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524
    [No Abstract]   [Full Text] [Related]  

  • 6. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated
    Sharma S; Srivastava S; Shrivastava A; Malik R; Almalki F; Saifullah K; Alam MM; Shaqiquzzaman M; Ali S; Akhter M
    J Biomol Struct Dyn; 2020 Nov; 38(18):5349-5361. PubMed ID: 31813365
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Martins MCMR; Pantaleao SQ; de Oliveira Almeida M; Weber KC; Honorio KM
    Med Chem; 2021; 17(3):247-263. PubMed ID: 31995015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis.
    Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J
    Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
    Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4.
    Mishra A; Cross M; Hofmann A; Coster MJ; Karim A; Sattar A
    J Comput Biol; 2019 Dec; 26(12):1470-1486. PubMed ID: 31390221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay.
    Vawhal PK; Jadhav SB; Kaushik S; Panigrahi KC; Nayak C; Urmee H; Khan SL; Siddiqui FA; Islam F; Eftekhari A; Alzahrani AR; Azlina MFN; Sarker MMR; Ibrahim IAA
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
    Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors.
    Upadhyay J; Gajjar A; Suhagia BN
    Curr Drug Discov Technol; 2019; 16(4):426-436. PubMed ID: 30255759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.
    Abouelkheir M; El-Metwally TH
    Eur J Pharmacol; 2019 Nov; 862():172638. PubMed ID: 31491403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation.
    Xing J; Li Q; Zhang S; Liu H; Zhao L; Cheng H; Zhang Y; Zhou J; Zhang H
    Chem Biol Drug Des; 2014 Sep; 84(3):364-77. PubMed ID: 24674599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
    Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
    Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus.
    Kalhotra P; Chittepu VCSR; Osorio-Revilla G; Gallardo-Velazquez T
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32075130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure-activity relationship-based artificial intelligence and molecular docking of hit compounds.
    Hermansyah O; Bustamam A; Yanuar A
    Comput Biol Chem; 2021 Dec; 95():107597. PubMed ID: 34800858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4).
    Pantaleão SQ; Philot EA; de Oliveira Almeida M; Lima AN; de Sairre MI; Scott AL; Honorio KM
    Curr Top Med Chem; 2020; 20(3):209-226. PubMed ID: 31878857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
    Meduru H; Wang YT; Tsai JJ; Chen YC
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.